Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial

BACKGROUND/AIMS: Solifenacin, a muscarinic type 3 receptor antagonist, is used to treat overactive bladder in adults. The aim of this study is to examine the efficacy of solifenacin on the symptomatic relief of diarrhea predominant irritable bowel syndrome (IBS-D). METHODS: A total of 20 patients wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Fukushima, Yasushi, Suzuki, Hidekazu, Matsuzaki, Juntaro, Kiyosue, Arihiro, Hibi, Toshifumi
Format: Artigo
Language:Inglês
Published: Korean Society of Neurogastroenterology and Motility 2012
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3400820/
https://ncbi.nlm.nih.gov/pubmed/22837880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm.2012.18.3.317
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items